Episode 7: Case Study — InteractSafe.com and the 30-Day Audit

About This Episode

The series finale of the original 7-episode arc. This episode examines the massive health information gap between GLP-1 medications — Ozempic, Wegovy, Mounjaro, Zepbound — and the lifestyle substances millions of users actually combine with them: cannabis, alcohol, caffeine, supplements.

Mainstream medical platforms are too slow, too cautious, and too liability-averse to cover these questions. InteractSafe.com was built specifically for this empty room, anchored by the 40-year clinical expertise and NPI number of Sanford A. Orloff, RPh (ret).

The episode also covers the "happy accident" of SeveranceScore.com — a cultural signal (the Severance TV show) that pointed to a real information gap in severance package benchmarking data. And it closes with the Thirty-Day Audit: the complete step-by-step roadmap to find, claim, and build your own empty room.

Key Takeaways

The GLP-1 + lifestyle interaction gap is a perfect ESA signal: massive demand (50M+ US users), zero authoritative consumer resources, major platforms too slow to move. InteractSafe owns this space.
Pharmacist review is the credibility layer that separates InteractSafe from generic AI-generated health content. Sanford A. Orloff, RPh (ret), NPI 1518289974, provides 40 years of clinical oversight.
SeveranceScore is an example of a "cultural signal" — a TV show created massive awareness of a real unmet information need (severance benchmarking data). Cultural moments create temporary empty rooms.
The Thirty-Day Audit has four stages: (1) define your territory, (2) run the Empty Result Test on 20 specific queries, (3) identify the one most buildable signal, (4) ship the Minimum Viable Authority within 30 days.
The window closes faster than you think. Once a topic starts appearing in mainstream media, you have weeks, not months, before the room fills.
The ESA pattern across all case studies is identical: GamblersDepot (2003), crowdfunding (2012), ShieldWord (2022), InteractSafe (2024). Same instinct, different verticals.

InteractSafe.com — GLP-1 and lifestyle interaction safety
GLP-1 & Cannabis Interaction Guide
SeveranceScore.com — severance package benchmarking
Book: books2read.com/earlysignalarbitrage

Case Study — InteractSafe.com and the 30-Day Audit

About This Episode

Key Takeaways

Related